Pentraxin 3: A Potential Novel Predictor for Neonatal Pulmonary Hypertension

Open Access Macedonian Journal of Medical Sciences - Macedonia
doi 10.3889/oamjms.2019.638
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

ID Design 2012/DOOEL Skopje

Related search

Pentraxin-3

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Potential of Proteinase-Activated Receptors as a Novel Target for Treatment of Pulmonary Hypertension

Folia Pharmacologica Japonica
Pharmacology
2014English

A Potential Role for Insulin Resistance in Experimental Pulmonary Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council
2016English

Platelet Activation in Experimental Murine Neonatal Pulmonary Hypertension

Physiological Reports
Physiology
2020English

Pentraxin 3 Long (PTX3)

Science-Business eXchange
2014English

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension

International Journal of Rheumatology
RheumatologyImmunology
2010English

CCL21 as a Potential Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Potential Interventions Against BMPR2-Related Pulmonary Hypertension

Advances in Pulmonary Hypertension
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy